This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_SCLC_EXALLC for full statistics.
Small cell lung cancer
C3_SCLC
non-small cell lung carcinoma: A group of at least three distinct histological types of lung cancer, including non-small cell squamous cell carcinoma, adenocarcinoma, and large cell carcinoma. Non-small cell lung carcinomas have a poor response to conventional chemotherapy.
Endpoint definition
↥
FinnGen phenotype data
392423 individuals
Apply sex-specific rule None
392423
Check conditions
HLP_C3_SCLC
700
Check pre-conditions, main-only, mode, registry filters
Cause of death: ICD-10
C34
Cause of death: ICD-9
162
Cause of death: ICD-8
162
Cancer registry: Topography ICD-O-3
C34
Cancer registry: Morphology ICD-O-3
8041
Cancer registry: Behaviour codes
3
2 out of 7 registries used, show all original rules.
700
Check minimum number of events None
700
Remove individuals based on genotype QC
676
C3_SCLC
Control definitions
Control conditions
not HLP_C3_SCLC
Extra metadata
Level in the ICD hierarchy
C
First used in FinnGen datafreeze
DF8
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Small cell lung cancer
based on the number of shared cases.
Broader endpoints:
- Small cell lung cancer (controls excluding all cancers)
- Small cell lung cancer
- Malignant neoplasm of bronchus and lung
- Malignant neoplasm of bronchus and lung (controls excluding all cancers)
- Malignant neoplasm of respiratory system and intrathoracic organs
Narrower endpoints:
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 676 | 126 | 550 |
| Unadjusted prevalence (%) | 0.18 | 0.06 | 0.33 |
| Mean age at first event (years) | 70.36 | 66.38 | 71.27 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: C3_SCLC – Small cell lung cancer
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Small cell lung cancer
↥Endpoint not on priority list, no data to show.